These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1348014)

  • 1. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
    Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
    Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma.
    Ogawa O; Kakehi Y; Ogawa K; Koshiba M; Sugiyama T; Yoshida O
    Cancer Res; 1991 Feb; 51(3):949-53. PubMed ID: 1671000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic deletions in renal tumors: histopathological correlations.
    Presti JC; Reuter VE; Cordon-Cardo C; Mazumdar M; Fair WR; Jhanwar SC
    Cancer Res; 1993 Dec; 53(23):5780-3. PubMed ID: 8242636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
    Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
    Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion mapping in human renal cell carcinoma.
    Bergerheim U; Nordenskjöld M; Collins VP
    Cancer Res; 1989 Mar; 49(6):1390-6. PubMed ID: 2924296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cellular characterization of human renal cell carcinoma cell lines.
    Anglard P; Trahan E; Liu S; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
    Cancer Res; 1992 Jan; 52(2):348-56. PubMed ID: 1345811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.
    Anglard P; Tory K; Brauch H; Weiss GH; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
    Cancer Res; 1991 Feb; 51(4):1071-7. PubMed ID: 1671754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
    Béroud C; Fournet JC; Jeanpierre C; Droz D; Bouvier R; Froger D; Chrétien Y; Maréchal JM; Weissenbach J; Junien C
    Genes Chromosomes Cancer; 1996 Dec; 17(4):215-24. PubMed ID: 8946203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK; Batsakis JG; Wang G; Lee MS
    Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of genetic alterations and progression of primary breast cancer.
    Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma.
    Schwerdtle RF; Störkel S; Neuhaus C; Brauch H; Weidt E; Brenner W; Hohenfellner R; Huber C; Decker HJ
    Cancer Res; 1996 Jul; 56(13):2927-30. PubMed ID: 8674042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methylation of promoter region of RASSF1A gene and frequencies of allelic imbalances in chromosome 3 critical regions are correlated with progression of clear cell renal cell carcinoma].
    Loginov VI; Khodyrev DS; Pronina IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Braga EA
    Mol Biol (Mosk); 2009; 43(3):429-38. PubMed ID: 19548529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
    Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA
    Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic mechanisms in esophageal carcinogenesis: frequent deletion of 3p and 17p in premalignant lesions.
    Shimada M; Yanagisawa A; Kato Y; Inoue M; Shiozaki H; Monden M; Nakamura Y
    Genes Chromosomes Cancer; 1996 Mar; 15(3):165-9. PubMed ID: 8721680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas.
    Sano T; Tsujino T; Yoshida K; Nakayama H; Haruma K; Ito H; Nakamura Y; Kajiyama G; Tahara E
    Cancer Res; 1991 Jun; 51(11):2926-31. PubMed ID: 2032230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
    Chino K; Esumi M; Ishida H; Okada K
    J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.